𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Horner syndrome in a newly diagnosed patient with high risk precursor b-cell acute lymphoblastic leukemia

✍ Scribed by Thomas J. Fountaine; Brooke Miller; Yousuf M. Khalifa; Jeffrey R. Andolina

Book ID
112168066
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
55 KB
Volume
59
Category
Article
ISSN
1545-5009

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Gemtuzumab, fludarabine, cytarabine, and
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes
✍ Apostolia Tsimberidou; Elihu Estey; Jorge Cortes; Deborah Thomas; Stefan Faderl; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Background: Gemtuzumab is used to treat patients with previously untreated or recurrent acute myelogenous leukemia (aml). the fludarabine and cytarabine (ara-c) regimen is active in these patients. resistance to gemtuzumab is associated with blast multidrug resistance (mdr). the objectives of th